Market cap
$67.469 M
$5.28 -1.12%
Close of 7 Aug 2026
Revenue
$200.0K
#3592 by revenue
Earnings
-$26.2M
Loss-making
Shares outstanding
11,778,307
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Clene are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.